Europe Pharmaceutical Filtration Market

The Europe pharmaceutical filtration market is projected to reach USD 5.95 billion by 2030 from USD 4.05 billion in 2025, registering a CAGR of 8.0% between 2025 and 2030. The growth of the Europe pharmaceutical filtration market can be attributed to several key factors, including the rising production of biologics and vaccines under strict EU quality rules, which is expected to boost demand for advanced pharmaceutical filtration.

To know about the assumptions considered for the study download the pdf brochure

The Europe pharmaceutical filtration industry observes a strong global footprint with different players operating at the regional level, such as Merck KGaA (Germany), Sartorius AG (Germany), Eaton Corporation Plc (Ireland), Porvair Plc (UK), Donaldson Company, Inc. (US), Alfa Laval Corporate AB (Sweden), and MMS AG (Germany), among others. As conventional membrane and depth filters evolve to include high-performance solutions for single-use bioprocessing, virus removal, and sterile fill-finish applications, these companies are actively supporting the research & development of complex biologics and advanced therapies. By investing in new production facilities, regional partnerships, and technology upgrades, they aim to strengthen global reach, improve contamination control, and offer integrated filtration platforms that enhance manufacturing efficiency and regulatory compliance for their biopharmaceutical customers.

In April 2024, Merck invested in a new research center at its global headquarters in Darmstadt. This investment aims to strengthen Merck's leading position in key technologies related to the development and manufacturing of novel medicines. Additionally, in January 2023, Sartorius AG and RoosterBio signed a collaboration agreement to provide purification solutions and establish scalable downstream manufacturing processes for exosome-based therapies.

Merck KGaA (US)

Merck KGaA (Germany) has established itself as one of the top five market leaders of pharmaceutical filtration solutions in Europe. Through its MilliporeSigma entity, Merck offers depth filters, membranes, and single-use assemblies that cater to various life science applications, ranging from research & development to commercial manufacturing. The company focuses on integrating clarification, virus filtration, and sterile filtration into end-to-end bioprocessing platforms, helping manufacturers improve yield, robustness, and scalability for biologics, vaccines, and advanced therapies. Continuous investment in European production sites and technical centers strengthens Merck’s ability to support rapid facility start-ups, process intensification, and stringent regulatory compliance.

Sartorius AG (US)

Sartorius AG (Germany) plays a central role in the Europe pharmaceutical filtration market through its comprehensive single-use bioprocess and sterilizing-grade filtration offerings. Its portfolio includes filter capsules, TFF systems, virus-removal solutions, and automated skids that connect upstream, downstream, and final fill-finish operations, enabling flexible and high-throughput manufacturing of monoclonal antibodies, vaccines, and cell & gene therapies. Sartorius is actively expanding capacity and digital capabilities, combining filtration with process control, analytics, and data tools to help customers shorten development timelines and achieve consistent, regulatory-grade product quality.  

Market Ranking

The Europe pharmaceutical filtration market is characterized by the robust presence of large-scale companies, including Merck KGaA (Germany), Sartorius (Germany), Eaton Corporation (Ireland), Porvair Filtration Group (UK), and Donaldson Company (US). These companies collectively contribute to the market growth of pharma filtration in the Europe region.

The topmost contributor to the regional market is Merck KGaA. The company's sterilizing-grade membranes, virus filtration systems, and single-use assemblies support high-purity biologics production, while its M Lab Collaboration Centers across Europe enhance customer access to process optimization and validation expertise. The dominance of Sartorius in the pharmaceutical filtration industry has helped the company to attain a leading position in the regional market. Among many other offerings are integrated sterile filtration trains and advanced membrane technologies.

The Europe pharmaceutical filtration market is evolving rapidly, mainly due to investments made by key players in single-use filtration systems, high-purity membrane technologies, automated process controls, and integrated bioprocessing platforms. The remainder of the market comprises regional filtration suppliers and niche technology developers. These players are expanding through targeted innovation, localized partnerships, and customized filtration solutions tailored to small-scale biomanufacturers, emerging therapy developers, and facilities requiring flexible, application-specific filtration capabilities.

Related Reports:

Europe Pharmaceutical Filtration Market by Product [Membrane Filter, Depth Filter, Virus Filter, Air Filter, Assemblies, Systems (Single-use)], Technique (Ultrafiltration), Type (Sterile), Application (API, Protein), Scale, End User - Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com